Related Experiment Video
Updated: Sep 28, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Resolved GH excess and arginine vasopressin deficiency following pituitary apoplexy
Bhavapriya Mani1, Charles B Stevenson2,3, Sarah Swauger1,4
1Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Abstract:
A 10-year, 8-month-old male presented with polyuria, polydipsia, and secondary nocturnal enuresis for 4 months following a severe headache. Initial fasting studies raised concern for partial arginine vasopressin deficiency (AVP-D). Brain magnetic resonance imaging revealed a possible pituitary adenoma vs artifact. His height was >99th percentile; he was prepubertal and growth charts demonstrated growth velocity >7.5 cm/year for the past 2 years. Additional testing showed markedly elevated IGF-1 and IGF-binding protein 3. He passed a water-deprivation test, ruling out AVP-D. He underwent a GH suppression test that revealed no suppression, suggesting GH excess. Repeat magnetic resonance imaging delineated a cystic pituitary lesion, most consistent with Rathke cleft cyst or hemorrhagic adenoma. Surgery was not recommended because the hematoma obscured visualization of any underlying tumor and evacuation could result in indiscriminate removal of the native gland. Serial imaging demonstrated continued retraction of the hematoma and tumor complex over 10 months. His AVP-D resolved, growth velocity slowed, and growth factors normalized over 13 months without intervention. Tall stature with increased growth velocity in prepubertal children should raise concern for GH excess. GH excess secondary to GH-secreting pituitary adenomas may spontaneously resolve if pituitary apoplexy occurs.
More Related Videos
07:03A Low Mortality Rat Model to Assess Delayed Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage
Published on: January 17, 2013
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Hepatic Encephalopathy